title: Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells.
abstract: Immunotherapy can be used to induce immunological tolerance by a number of different protocols. During the last decade the ability to use tolerogenic dendritic cells (DCs) to prevent autoimmunity has received much attention. Many studies have attempted to use immature or semi-mature DCs to induce tolerance in the non-obese diabetic (NOD) mouse model of human type 1 diabetes. However, most studies to date have used protocols in which generation of DCs involved a culture step in fetal bovine serum (FBS)-supplemented medium which may affect tolerance induction in a non-specific fashion. Indeed, several studies have shown that DCs cultured in the presence of FBS will induce a powerful T helper type 2 (Th2) immune response towards FBS-related antigens which can suppress an ongoing immune response. Hence, this may interfere with diabetes development in the NOD mouse by induction of immune deviation rather than by antigen-specific tolerance. In order to test whether antigen-specific tolerance induction by DC therapy is feasible in the NOD mouse, we therefore generated immature DCs using autologous serum [normal mouse serum (NMS)-supplemented cultures] instead of FBS, and we show that these DCs can protect NOD mice from diabetes, if pulsed with insulin-peptide antigens before adoptive transfer. Our data therefore support that DC therapy is able to prevent diabetes in the NOD mouse in an antigen-specific manner.
authors.affiliation: Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark. csha@novonordisk.com
authors.forename: C
authors.initials: C
authors.lastname: Haase
authors.forename: L
authors.initials: L
authors.lastname: Yu
authors.forename: G
authors.initials: G
authors.lastname: Eisenbarth
authors.forename: H
authors.initials: H
authors.lastname: Markholst
mesh_terms: D000818:Animals; D000941:Antigens / Q000276:immunology*; D002417:Cattle; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000628:therapy*; D005260:Female; D007108:Immune Tolerance; D016219:Immunotherapy, Adoptive; D051379:Mice; D016688:Mice, Inbred NOD; D018418:Th2 Cells / Q000276:immunology*; D014182:Transplantation, Autologous
chemical_list: D000941:Antigens